All Stories

  1. The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model
  2. Tissue engineered vascular grafts for pediatric cardiac surgery
  3. Tissue-engineered Vascular Grafts in Children With Congenital Heart Disease: Intermediate Term Follow-up
  4. Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts
  5. Toward a patient-specific tissue engineered vascular graft
  6. Novel application and serial evaluation of tissue-engineered portal vein grafts in a murine model
  7. Tissue-engineered vascular grafts for congenital cardiac disease: Clinical experience and current status
  8. Fast-degrading bioresorbable arterial vascular graft with high cellular infiltration inhibits calcification of the graft
  9. What is the best material for extracardiac Fontan operation?
  10. Tissue Engineering in Vascular Medicine
  11. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model
  12. Tropoelastin inhibits intimal hyperplasia of mouse bioresorbable arterial vascular grafts
  13. TRANSMURAL MACROPHAGE MIGRATION IN TISSUE ENGINEERED VASCULAR GRAFT PROMOTES EXTRACELLULAR MATRIX FORMATION FOR VASCULAR REMODELING MORE THAN HOST CIRCULATING INFLAMMATORY CELL MIGRATION
  14. Nanofiber composites in vascular tissue engineering
  15. Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model
  16. Current Status of Tissue Engineering Heart Valve
  17. Novel Bioresorbable Vascular Graft With Sponge-Type Scaffold as a Small-Diameter Arterial Graft
  18. Deconstructing the Tissue Engineered Vascular Graft: Evaluating Scaffold Pre-Wetting, Conditioned Media Incubation, and Determining the Optimal Mononuclear Cell Source
  19. Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model
  20. Pilot Mouse Study of 1 mm Inner Diameter (ID) Vascular Graft Using Electrospun Poly(ester urea) Nanofibers
  21. tissue engineering
  22. Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation time
  23. Neotissue remodeling of tissue-engineered arterial graft
  24. Long-Term Functional Efficacy of a Novel Electrospun Poly(Glycerol Sebacate)-Based Arterial Graft in Mice
  25. Current Status of Tissue Engineered Vascular Graft in Pediatric Cardiac Surgery
  26. Effect of cell seeding on neotissue formation in a tissue engineered trachea
  27. A mouse model of endocardial fibroelastosis
  28. Current Status of Cardiovascular Tissue Engineering
  29. Evaluation of remodeling process in small-diameter cell-free tissue-engineered arterial graft
  30. Potential Molecular Mechanism of Retrograde Aortic Arch Stenosis in the Hybrid Approach to Hypoplastic Left Heart Syndrome
  31. Hemodynamic Characterization of a Mouse Model for Investigating the Cellular and Molecular Mechanisms of Neotissue Formation in Tissue-Engineered Heart Valves
  32. Influence of Posttransplant Lymphoproliferative Disorder on Survival in Children After Heart Transplantation
  33. Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous ModelSignificance
  34. The innate immune system contributes to tissue-engineered vascular graft performance
  35. Comparison of the Biological Equivalence of Two Methods for Isolating Bone Marrow Mononuclear Cells for Fabricating Tissue-Engineered Vascular Grafts
  36. Biomechanical Diversity Despite Mechanobiological Stability in Tissue Engineered Vascular Grafts Two Years Post-Implantation
  37. Development of Small Diameter Nanofiber Tissue Engineered Arterial Grafts
  38. A new tissue-engineered biodegradable surgical patch for high-pressure systems
  39. Contrasting Biofunctionalization Strategies for the Enhanced Endothelialization of Biodegradable Vascular Grafts
  40. TGFβR1 Inhibition Blocks the Formation of Stenosis in Tissue-Engineered Vascular Grafts
  41. First Report of Histological Evaluation of Human Tissue-Engineered Vasculature
  42. Preliminary Experience in the Use of an Extracellular Matrix (CorMatrix) as a Tube Graft: Word of Caution
  43. Comparison of a Closed System to a Standard Open Technique for Preparing Tissue-Engineered Vascular Grafts
  44. Well-organized neointima of large-pore poly(l-lactic acid) vascular graft coated with poly(l-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(l-lactic acid) graft in a mouse aortic implantation model
  45. Development of a Tissue-Engineering Vascular Graft for Use in Congenital Heart Surgery
  46. Targeted imaging of matrix metalloproteinase activity in the evaluation of remodeling tissue-engineered vascular grafts implanted in a growing lamb model
  47. Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
  48. Implantation of Inferior Vena Cava Interposition Graft in Mouse Model
  49. Vessel Bioengineering
  50. Vessel Regeneration and Bioengineering**Shuhei Tara and Ethan W. Dean contributed equally to the preparation of this manuscript and should be listed as cofirst authors.
  51. Tissue-Engineered Vascular Grafts in Pediatric Cardiovascular Surgery -Past, Now, and Future
  52. Stem cells in tissue-engineered blood vessels for cardiac repair
  53. Contributor contact details
  54. List of Contributors
  55. Tissue Engineering in the Vasculature
  56. Tissue Engineered Small-Diameter Arterial Graft: In Vivo Evaluation of an Electrospun Nanofiber Scaffold
  57. Concise Review: Tissue-Engineered Vascular Grafts for Cardiac Surgery: Past, Present, and Future
  58. Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again
  59. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts
  60. Modified Starnes Procedure in a Neonate With Severe Tricuspid Regurgitation
  61. Characterization of the Natural History of Extracellular Matrix Production in Tissue-Engineered Vascular Grafts during Neovessel Formation
  62. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts
  63. Development of an Operator-Independent Method for Seeding Tissue-Engineered Vascular Grafts
  64. Vascular tissue engineering: Towards the next generation vascular grafts
  65. Restoring Blood Vessels
  66. TISSUE ENGINEERED BLOOD VESSELS: FROM THE BENCH TO THE BEDSIDE AND BACK AGAIN (DEVELOPMENT OF A VASCULAR CONDUIT FOR USE IN CONGENITAL HEART SURGERY)
  67. Embryonic stem cell therapy; A novel cell delivery method
  68. Cell-Seeding Techniques in Vascular Tissue Engineering
  69. Tissue-engineered vascular grafts: does cell seeding matter?
  70. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling
  71. Late-term results of tissue-engineered vascular grafts in humans
  72. Characterization of small-diameter electrospun tissue-engineered arterial grafts
  73. Tissue-engineered arterial grafts: long-term results after implantation in a small animal model
  74. 114. Evaluation of the Role of Selective Cell Seeding on Neovessel Formation in Tissue Engineered Vascular Grafts
  75. Tissue-engineered Vascular Grafts Demonstrate Evidence of Growth and Development When Implanted in a Juvenile Animal Model
  76. 7C-3 In Vivo Assessment Method of Tissue-Engineered Vascular Wall Based on Quantitative Elastic Modulus Measurement
  77. Double-outlet right ventricle with left malposition of the great arteries and total anomalous pulmonary venous connection
  78. Clinical Application of Tissue Engineered Vascular Graft Utilizing Biodegradable Polymer Scaffold
  79. Tissue Engineered Heart Valves: Autologous Cell Seeding on Biodegradable Polymer Scaffold
  80. Tissue engineering of autologous aorta using a new biodegradable polymer
  81. Postischemic hyperthermia exacerbates neurologic injury after deep hypothermic circulatory arrest
  82. Creation Of Viable Pulmonary Artery Autografts Through Tissue Engineering
  83. Diastolic ventricular function immediately before and after Fontan procedure
  84. Tissue engineering heart valves: Valve leaflet replacement study in a lamb model
  85. Konno Procedure for Congenital Aortic Stenosis with a Single Coronary Artery from the Left Coronary Sinus
  86. CHAPTER 9. Smart Biomaterials for Cardiovascular Tissue Engineering